Qualisys

The following members have been appointed to Qualisys Holdings’ Nomination Committee for the 2026 Annual General Meeting:

Michael Jönsson, appointed by Vätterledens Invest AB
David Jallo, appointed by Ramhill AB
Anna Sundberg, appointed by Handelsbanken Fonder

In addition, the Chairman of the Board, Peter Gille, will be a member of the nomination committee except when the committee is to deal with matters concerning himself.

The appointments have been made in accordance with the principles for the company’s Nomination Committee established at the Annual General Meeting of Qualisys Holding on May 14, 2025. The shareholders that have appointed the members of the Nomination Committee represented in aggregate approximately 47 percent of all shares in the company as of September 30, 2025.

The Nomination Committee shall prepare and submit proposals to the Annual General Meeting regarding: (i) election of Chairman of the Meeting, (ii) election of board members, (iii) election of Chairman of the Board, (iv) resolution on board remuneration with the division between the Chairman and other board members, (v) remuneration to the members of the Remunderation and Audit Committee, (vi) election of auditors, (vii) resolution on remuneration of auditors, and (viii) to the extent deemed necessary, proposals for changes to the current principles for the Nomination Committee.

The Annual General Meeting of Qualisys Holding AB (publ) will be held on Monday, May 18, 2026 in Gothenburg. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so in due time before the 2026 Annual General Meeting so that the Nomination Committee has time to consider the proposal, preferably by February 28, 2026. Proposals may be sent to Qualisys Holding AB (publ), Att: Nomination Committee, Kvarnbergsgatan 2, 411 05 Göteborg, Sweden.

Gothenburg, Sweden, November 10, 2025
Qualisys Holding AB (publ)

The press release, in its entirety, is available through the attachment or via:Press releases – Qualisys Investors

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Ingemar Pettersson, CEO
+46 31-336 94 18
Annelie Skafte Persson, CFO
+46 31-336 94 37

About Qualisys

Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore and Shanghai. Qualisys is certified according to ISO 9001:2015, the clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.